Modified-release prednisone for polymyalgia rheumatica: a multicentre, randomised, active-controlled, double-blind, parallel-group study.

RMD Open · 2017 · PMC5372105 · PMID 28405475

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

Conclusions The study showed a clear trend for favourable short-term efficacy of MR prednisone versus IR prednisone in early treatment of PMR.

also in 19,460 other papers

an evident trendno p-value reported

However, sensitivity analysis on the full analysis population showed an evident trend favouring MR prednisone (N=62; treatment difference: 15.56%; 95% CI −9.16% to 40.28%).

also in 268 other papers

showed a trendno p-value reported

Sensitivity analysis on the FAP showed a trend in favour of MR prednisone (treatment difference: 15.56%; 95% CI −9.16% to 40.28%).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.